Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Synthomer plc    SYNT   GB0009887422


Real-time Estimate Quote. Real-time Estimate CHI-X - 04/08 11:30:00 am
257.3 GBp   +2.27%
03/19UPDATE ON COVID-19 : Synthomer's Commitment During the Coronavirus Pandemic
03/05SYNTHOMER : Preliminary Results for the year ended 31 Dec 2019
01/31SYNTHOMER : Director Declaration
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Synthomer : Acquisition of OMNOVA receives EC clearance

share with twitter share with LinkedIn share with facebook
share via e-mail
01/15/2020 | 09:43am EDT

Acquisition of OMNOVA receives EC clearance

Released : 15 Jan 2020 14:21

RNS Number : 9271Z

Synthomer PLC

15 January 2020

15 January 2020

Synthomer receives European Commission clearance for OMNOVA acquisition

Synthomer plc ("Synthomer" or the "Company") today received conditional clearance from the European Commission regarding its proposed acquisition of OMNOVA Solutions Inc ("OMNOVA").

Following its Phase 1 investigation, the European Commission concluded that the transaction, as modified by the commitments offered by Synthomer, does not raise any competition concerns. The commitments require divestment of Synthomer's small VP Latex business in Germany. The VP Latex business represented less than 0.5% of Synthomer's 2018 sales volume. Whilst financially immaterial, the sale process must be finalised prior to the closing of Synthomer's acquisition of OMNOVA. This represents a structural remedy offered by Synthomer to address any concerns regarding the overlap between the two companies' VP Latex operations.

Synthomer has already received a number of expressions of interest for this business and will now proceed with the sale process, with completion of the acquisition of OMNOVA expected late Q1 2020. The transaction also remains subject to regulatory approval from the Turkish authorities, which is expected to be received early in February.

Calum MacLean, Chief Executive of Synthomer, commented:

"We are pleased to have received European Commission clearance for the acquisition of OMNOVA but note the structural remedy required to divest our small VP Latex business in Germany. The acquisition of OMNOVA is strategically and financially compelling. It will materially expand our international business into North America, and grow our presence in Europe and Asia, as well as provide an attractive financial profile with significant expected synergy benefits. We are now working on the divestment as quickly as possible, which will enable us to conclude the OMNOVA acquisition and focus on taking the combined business to the next level."

- Ends -


Calum MacLean, Chief Executive Officer

Tel: + 44 1279 436211

Stephen Bennett, Chief Financial Officer

Tim Hughes, President - Corporate Development

Charles Armitstead, Teneo

Tel: + 44 7703 330 269

Matthew Denham, Teneo

Tel: + 44 7825 735 596

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.comor visit www.rns.com.




Synthomer plc published this content on 15 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 January 2020 14:42:01 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SYNTHOMER PLC
03/19UPDATE ON COVID-19 : Synthomer's Commitment During the Coronavirus Pandemic
03/05SYNTHOMER : Preliminary Results for the year ended 31 Dec 2019
01/31SYNTHOMER : Director Declaration
01/22SYNTHOMER : European Coatings Journal Interviews Synthomer on Trends in Architec..
01/15SYNTHOMER : Acquisition of OMNOVA receives EC clearance
2019LONDON STOCK EXCHANGE : FTSE 100 snaps four-day winning run amid Brexit worries
2019SYNTHOMER : Q3 Trading Update
2019SYNTHOMER : Omnova shareholders approval
2019SYNTHOMER PLC : Ex-dividend day for interim dividend
2019SYNTHOMER : Interim Results for 6 months ended 30 June 2019
More news
Financials (GBP)
Sales 2019 1 498 M
EBIT 2019 127 M
Net income 2019 82,1 M
Debt 2019 124 M
Yield 2019 4,55%
P/E ratio 2019 12,2x
P/E ratio 2020 13,0x
EV / Sales2019 0,81x
EV / Sales2020 0,90x
Capitalization 1 095 M
Duration : Period :
Synthomer plc Technical Analysis Chart | SYNT | GB0009887422 | MarketScreener
Technical analysis trends SYNTHOMER PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 292,58  GBp
Last Close Price 257,80  GBp
Spread / Highest target 51,3%
Spread / Average Target 13,5%
Spread / Lowest Target -6,13%
EPS Revisions
Calum G. MacLean Chief Executive Officer & Executive Director
Neil Anthony Johnson Non-Executive Chairman
Martin Hallam President-SHE & Operations
Stephen Guy Bennett Chief Financial Officer & Executive Director
Alexander Gordon Catto Lead Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SYNTHOMER PLC-27.13%1 319
ECOLAB INC.-11.49%46 009
GIVAUDAN3.53%29 801
SIKA AG-10.48%23 773
SYMRISE AG-4.90%13 209